
Vefax 75mg Tablet XR
Marketer
Micron Biotech
Salt Composition
Venlafaxine (75mg)
Overview Vefax 75mg Tablet XR
Axonil 75mg Extended-Release Tablets treat anxiety and depressive disorders. This medication modifies brain chemistry, alleviating symptoms like restlessness, poor concentration, tiredness, excessive perspiration, rapid heartbeat, racing thoughts, and irritability. Axonil 75mg Extended-Release Tablets should be administered with food, at the same time daily for consistent blood levels. Missed doses should be taken immediately upon recall; complete the prescribed course, even with symptom improvement. Abrupt cessation is discouraged, as it might exacerbate symptoms. Common side effects include nausea, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, increased sweating, and sexual difficulties. Dizziness and drowsiness may occur; avoid driving or activities demanding concentration until the drug's effects are known. These side effects are usually transient and self-limiting. Consult your physician if they persist or are bothersome. Before starting Axonil 75mg Extended-Release Tablets, disclose any kidney, liver, or heart conditions, or a history of seizures. Report any unusual mood shifts, worsening depression, or suicidal ideation to your doctor immediately.
Uses of Vefax 75mg Tablet XR
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Vefax 75mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or divide it. Vefax 75mg Extended-Release Tablets should be taken with a meal.
Common Side effects of Vefax 75mg Tablet XR:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Vefax 75mg Tablet XR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 75mg extended-release Vefax tablet whole; avoid chewing, crushing, or breaking it. Take it with food.
How Vefax 75mg Tablet XR works:
Vefax 75mg Extended-Release tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vefax 75mg Tablet XR and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vefax 75mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vefax 75mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant. Close observation of infants for drowsiness and appropriate weight increase is recommended.
DrivingUNSAFE
Extended-release Vefax 75mg tablets can produce adverse reactions that may impair driving ability. These reactions include dizziness, confusion, and visual disturbances like blurred vision, all potentially affecting driving safety.
KidneyCAUTION
Extended-release Vefax 75mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Vefax 75mg extended-release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Vefax 75mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Vefax 75mg extended-release tablets might be necessary. Physician consultation is advised.
What if you forget to take Vefax 75mg Tablet XR :
Should you forget a Vefax 75mg Tablet XR dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual medication schedule. Never take a double dose.
Facts to Know About Vefax 75mg Tablet XR
| Label | Value |
|---|---|
| Chemical Category | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
| Action class | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
